Leading Head and Neck Surgical Oncologist Dr. Rodney Taylor will serve as Interim Chair of UMSOM Department of Otorhinolaryngology
Scott Strome, MD, FACS, Professor and Chair of the Department of Otorhinolaryngology – Head & Neck Surgery at the University of Maryland School of Medicine (UMSOM), has been named Executive Dean, College of Medicine and Vice Chancellor for Health Affairs at the University of Tennessee Health Science Center in Memphis, Tenn., effective October 1, 2018. UMSOM Dean E. Albert Reece, MD, PhD, MBA, announced that, Rodney Taylor, MD, MSPH, Associate Professor of Otorhinolaryngology-Head & Neck Surgery, will serve as Interim Chair.
Dr. Strome, who joined UMSOM in 2005, has served for the past 13 years as chair of the Department, which specializes in the diagnosis and treatment of ear, nose and throat disorders, including difficult to treat cancers of the throat, mouth, larynx, sinuses, and salivary glands. He also served as Interim Chair of the Department of Ophthalmology & Visual Sciences from 2012-2013, and the Department of Dermatology from 2015-2017. He was founder/former leader of the program in tumor immunology and immunotherapy within the Marlene and Stewart Greenebaum Comprehensive Cancer Center. He is also the Head of the Friedenwald house, one of four academic homes to which all medical students are assigned, and has led philanthropic efforts to reduce medical student debt.
“This is a tremendous opportunity for Dr. Strome,” said Dean Reece, MD, PhD, MBA, who is also Executive Vice President for Medical Affairs, UM Baltimore, and the John Z. and Akiko K. Bowers Distinguished Professor. “Given his leadership and experience in both research and clinical affairs, as well as his success in entrepreneurial management, he has the full range of qualifications and perspectives required to be a highly effective dean. We extend our deep appreciation to him for his years of outstanding service to the UMSOM, and wish him great success in this exciting, new opportunity.”
Dr. Strome is an internationally recognized head and neck surgeon, with expertise in the treatment of head and neck tumors, thyroid cancer, and diseases of the anterior skull base. He served as Chairman of two National Institutes of Health special emphasis panels and as a member on the Recombinant DNA Advisory Committee. He has excelled in creating drugs and procedures with direct clinical impact. He co-founded Gliknik Inc., a company that creates new therapies for cancer and immune/inflammatory disorders. Dr. Strome was recognized by the University of Maryland, Baltimore as the 2011 Entrepreneur of the Year, and by the University of Maryland Board of Regents as the 2013 Entrepreneur of the Year.
Dr. Rodney Taylor, who joined the faculty of the UMSOM Department of Otorhinolaryngology in 2001, has beenrecognized by local and national organizations as one of America’s top otolaryngologists. A graduate of Harvard College and Harvard Medical School, he completed both his internship and residency at the University of Michigan. While at Michigan, he studied Quality of Life instruments among head and neck cancer patients, and received his MS Degree in Public Health. At UMSOM, he is the Director of General Otorhinolaryngology, and the Chief of Otolaryngology at the Veteran’s Administration Medical Center at Baltimore. He is also Associate Chair for Research in the Department of Otorhinolaryngology, where he oversees more than 20-full time personnel in a laboratory with multiple grants including 6 NIH/federal grants. Dr. Taylor’s lab has successfully established mouse models to study head and neck cancer cell immortality mechanisms and behavior using xenografts.
“We are fortunate to have Dr. Taylor, who is widely respected across UMSOM and UMMS, to serve in this capacity,” Dean Reece said. “We are confident that he will provide exceptional leadership during this interim period.”
Dr. Strome added: “Dr. Taylor is a visionary leader with a national reputation as a Head and Neck surgeon, with a strong and collaborative portfolio of NIH funded research and with a passion for medical student and resident education. I have every confidence that he will be a fantastic chair.”
Dr. Strome leaves the Department in a particularly strong position. The clinical program is one of the largest head and neck cancer programs in the state of Maryland, and one of the largest solid tumor programs at UMMC. In research, the department ranked 20th in research funding among all medical schools in the nation. In education, the department saw seven of its last 10 graduating residents go on to fellowship training at top institutions. The department has also led various humanitarian missions to Haiti, Kenya, Vietnam and other countries.
UMSOM is planning to host a celebratory event for Dr. Strome on Sept. 4 at 4:00 p.m. in the Health Sciences Facility II Building Lobby (20 Penn Street). The entire UMSOM community is invited to wish continued success to Dr. Strome and Dr. Taylor.
About the University of Maryland School of Medicine
Commemorating its 210th Anniversary, the University of Maryland School of Medicine was chartered in 1807 as the first public medical school in the United States. It continues today as one of the fastest growing, top-tier biomedical research enterprises in the world -- with 43 academic departments, centers, institutes, and programs; and a faculty of more than 3,000 physicians, scientists, and allied health professionals, including members of the National Academy of Medicine and the National Academy of Sciences, and a distinguished recipient of the Albert E. Lasker Award in Medical Research. With an operating budget of more than $1 billion, the School of Medicine works closely in partnership with the University of Maryland Medical Center and Medical System to provide research-intensive, academic and clinically-based care for more than 1.2 million patients each year. The School has over 2,500 students, residents, and fellows, and nearly $450 million in extramural funding, with most of its academic departments highly ranked among all medical schools in the nation in research funding. As one of the seven professional schools that make up the University of Maryland Baltimore campus, the School of Medicine has a total workforce of nearly 7,000 individuals. The combined School and Medical System (“University of Maryland Medicine”) has an annual budget of nearly $6 billion and an economic impact in excess of $15 billion on the state and local community. The School of Medicine faculty, which ranks as the 8th-highest public medical school in research productivity, is an innovator in translational medicine, with 600 active patents and 24 start-up companies. The School works locally, nationally, and globally, with research and treatment facilities in 36 countries around the world. Visit medschool.umaryland.edu/